StockWatch
·
Pharmaceuticals
Board Meeting13 Aug 2026, 08:02 pm

Brooks Laboratories Board Approves Unaudited Q1 FY27 Results

AI Summary

Brooks Laboratories Ltd announced that its Board of Directors met on August 13, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026. The company has submitted these results along with a limited review report from its independent auditor, DM KH & Co. The financial statements were prepared in accordance with Indian Accounting Standard 34 (Ind AS 34) and other recognized accounting principles. The auditor's report states that based on their review, nothing came to their attention to suggest material misstatements in the accompanying unaudited standalone financial results. The meeting commenced at 4:00 PM and concluded at 6:00 PM. The information will also be available on the company's website.

Key Highlights

  • Board meeting held on August 13, 2026.
  • Unaudited financial results for Q1 FY27 approved.
  • Limited review report from auditor DM KH & Co submitted.
  • Results prepared as per Ind AS 34.
  • Information to be available on company website.